e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Cardiovascular consequences of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Unrecognised hypertension in patients screened for obstructive sleep apnoea
A. R. Proctor, R. Lamb, C. G. Billings, E. D. Moloney (Sheffield, United Kingdom)
Source:
Annual Congress 2005 - Cardiovascular consequences of OSA
Session:
Cardiovascular consequences of OSA
Session type:
Poster Discussion
Number:
371
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. R. Proctor, R. Lamb, C. G. Billings, E. D. Moloney (Sheffield, United Kingdom). Unrecognised hypertension in patients screened for obstructive sleep apnoea. Eur Respir J 2005; 26: Suppl. 49, 371
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Unrecognised systemic hypertension in patients with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 115s
Year: 2005
Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism?
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
Prevalence of stroke in obstructive sleep apnoea (OSA) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007
Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Source: Guidelines 2013
Year: 2013
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients.
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
Prevalence of obstructive airway disease in patients with obstructive sleep apnea
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Prevalence of thyroid disease in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013
Investigating for dyslipidemia in those being referred for suspected obstructive sleep apnoea
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Year: 2011
Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience
Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new?
Year: 2020
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Masked hypertension and obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 416s
Year: 2006
Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Comorbidities of obstructive sleep apnoea syndrome
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept